Enzo Biochem (NYSE:ENZ) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Enzo Biochem (NYSE:ENZ) in a research report report published on Wednesday. The firm issued a hold rating on the medical research company’s stock.

Enzo Biochem Trading Up 10.1 %

NYSE ENZ opened at $0.37 on Wednesday. Enzo Biochem has a 12 month low of $0.25 and a 12 month high of $1.28. The company’s 50 day simple moving average is $0.44 and its 200 day simple moving average is $0.76.

Enzo Biochem (NYSE:ENZ) last released its earnings results on Monday, March 17th. The medical research company reported ($0.02) EPS for the quarter. The business had revenue of $7.33 million during the quarter. Enzo Biochem had a negative return on equity of 7.96% and a negative net margin of 75.34%.

Hedge Funds Weigh In On Enzo Biochem

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Virtu Financial LLC acquired a new stake in Enzo Biochem during the 4th quarter valued at $35,000. Lepercq Multi Asset Fund purchased a new position in shares of Enzo Biochem during the fourth quarter valued at $88,000. Wittenberg Investment Management Inc. raised its position in Enzo Biochem by 60.1% during the fourth quarter. Wittenberg Investment Management Inc. now owns 187,537 shares of the medical research company’s stock valued at $134,000 after buying an additional 70,400 shares during the period. Geode Capital Management LLC lifted its stake in Enzo Biochem by 3.3% in the 3rd quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock worth $413,000 after acquiring an additional 11,742 shares in the last quarter. Finally, Mink Brook Asset Management LLC acquired a new stake in Enzo Biochem during the 4th quarter worth about $577,000. Institutional investors and hedge funds own 36.90% of the company’s stock.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.